{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:31:37Z","timestamp":1782124297493,"version":"3.54.5"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T00:00:00Z","timestamp":1483401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0169117","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T22:04:09Z","timestamp":1483999449000},"page":"e0169117","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Relationship between Hemoglobin Levels Corrected by Interdialytic Weight Gain and Mortality in Japanese Hemodialysis Patients: Miyazaki Dialysis Cohort Study"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0135-599X","authenticated-orcid":true,"given":"Tatsunori","family":"Toida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Iwakiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouichi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,1,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-6386(96)90130-4","article-title":"The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease","volume":"28","author":"RN Foley","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1681\/ASN.2005090997","article-title":"Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients","volume":"17","author":"DL Regidor","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"ref3","first-page":"280","article-title":"Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study","volume":"35","author":"J Pascual","year":"1991","journal-title":"Clin Nephrol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1093\/ndt\/gfr697","article-title":"Systematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients","volume":"27","author":"KL Johansen","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1681\/ASN.V12122797","article-title":"Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis","volume":"12","author":"K Kalantar-Zadeh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/1744-9987.12155","article-title":"Low hemoglobin levels and hypo-responsiveness to erythropoiesis-stimulating agent associated with poor survival in incident Japanese hemodialysis patients","volume":"18","author":"T Akizawa","year":"2014","journal-title":"Ther Apher Dial"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2004121039","article-title":"Double\u2012blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease","volume":"16","author":"PS Parfrey","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"A Besarab","year":"1998","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7326\/0003-4819-153-1-201007060-00252","article-title":"Meta\u2012analysis: erythropoiesis\u2012stimulating agents in patients with chronic kidney disease","volume":"153","author":"SC Palmer","year":"2010","journal-title":"Ann Intern Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2215\/CJN.02100508","article-title":"Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapy","volume":"3","author":"RN Foley","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2215\/CJN.04950908","article-title":"Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trial","volume":"4","author":"RN Foley","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1093\/ndt\/gfr697","article-title":"Systematic review of the impact of erythropoiesis\u2012stimulating agents on fatigue in dialysis patients","volume":"27","author":"KL Johansen","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archinternmed.2009.112","article-title":"The impact of selecting a high hemoglobin target level on health\u2012related quality of life for patients with chronic kidney disease: a systematic review and meta\u2012analysis","volume":"169","author":"FM Clement","year":"2009","journal-title":"Arch Intern Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.2012.76","article-title":"The health\u2012related quality of life was not improved by targeting higher hemoglobin in the Normal Hematocrit Trial","volume":"82","author":"DW Coyne","year":"2012","journal-title":"Kidney Int"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/ndt\/14.5.1340","article-title":"Target Haematocrit during erythropoietin treatment in dialysis patients. Which value is true-functional haematocrit?","volume":"14","author":"D Vlassopoulos","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/ajkd.2002.32007","article-title":"Predialysis versus postdialysis hematocrit evaluation during erythropoietin therapy","volume":"39","author":"E Movilli","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1053\/ajkd.2002.34913","article-title":"Influence of the cyclic variation of hydration status on hemoglobin levels in hemodialysis patients","volume":"40","author":"V Bellizzi","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2369-13-60","article-title":"Should we adjust erythropoiesis-stimulating agent dosage to postdialysis hemoglobin levels? A pilot study","volume":"13","author":"N Castillo","year":"2012","journal-title":"BMC Nephrol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/MJT.0b013e3181b28b59","article-title":"Anemia management with darbepoetin-alfa in outpatient hemodialysis patients switched from epoetin-alfa: a community hospital experience","volume":"17","author":"V Agrawal","year":"2010","journal-title":"Am J Ther"},{"key":"ref20","first-page":"73","article-title":"Long-term intravenous epoetin-alpha\/ darbepoetin-alpha ratio in iron-replete hemodialysis patients","volume":"20","author":"A Icardi","year":"2007","journal-title":"J Nephrol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/sj.ki.5000186","article-title":"Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS","volume":"69","author":"R Saran","year":"2006","journal-title":"Kidney Int"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000335256","article-title":"Factors predicting erythropoietin resistance among maintenance hemodialysis patients","volume":"33","author":"S Mallick","year":"2012","journal-title":"Blood Purif"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJMoa071533","article-title":"Efficacy and safety of epoetin alfa in critically ill patients","volume":"357","author":"HL Corwin","year":"2007","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10157-010-0288-x","article-title":"Serum ferritin predicts prognosis in hemodialysis patients: the Nishinomiya study","volume":"14","author":"Y Hasuike","year":"2010","journal-title":"Clin Exp Nephrol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1053\/ajkd.2001.22433","article-title":"Serum ferritin is a marker of morbidity and mortality in hemodialysis patients","volume":"37","author":"K Kalantar-Zadeh","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/ndt\/14.9.2156","article-title":"The effect of age, diabetes, and other comorbidity on the survival of patients on dialysis: a systematic quantitative overview of the literature","volume":"14","author":"JG Johnson","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJM199301213280304","article-title":"Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia","volume":"328","author":"DS Rao","year":"1993","journal-title":"N Engl J Med"},{"issue":"4","key":"ref28","first-page":"279","article-title":"KDIGO clinical practice guideline for anemia in chronic kidney disease","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/j.ajkd.2004.03.023","article-title":"Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"44","author":"RL Pisoni","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ki.2010.108","article-title":"International trends in erythropoietin use and hemoglobin levels in hemodialysis patients","volume":"78","author":"PA McFarlane","year":"2010","journal-title":"Kidney Int"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1681\/ASN.V1061309","article-title":"Hematocrit levels and hospitalization risks in hemodialysis patients","volume":"10","author":"H Xia","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1681\/ASN.V103610","article-title":"Hematocrit level and associated mortality in hemodialysis patients","volume":"10","author":"JZ Ma","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-6386(96)90130-4","article-title":"The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease","volume":"28","author":"RN Foley","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/gfg458","article-title":"Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"19","author":"F Locatelli","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1093\/ndt\/gfq073","article-title":"Mortality in incident haemodialysis patients: time-dependent haemoglobin levels and erythropoiesis-stimulating agent dose are independent predictive factors in the ANSWER study","volume":"25","author":"J Fort","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1093\/ndt\/gfn346","article-title":"Japanese haemodialysis anaemia management practices and outcomes (1999\u20132006): results from the DOPPS","volume":"23","author":"T Akizawa","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"c91","DOI":"10.1159\/000335979","article-title":"Disappearance of association in diabetic patients on hemodialysis between anemia and mortality risk: the Japan dialysis outcomes and practice pattern study","volume":"120","author":"M Inaba","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/1744-9987.12155","article-title":"Low hemoglobin levels and hypo-responsiveness to erythropoiesis-stimulating agent associated with poor survival in incident Japanese hemodialysis patients","volume":"18","author":"T Akizawa","year":"2014","journal-title":"Ther Apher Dial"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e0140241","DOI":"10.1371\/journal.pone.0140241","article-title":"The Korean clinical research center for end-stage renal disease study validates the association of hemoglobin and erythropoiesis-stimulating agent dose with mortality in hemodialysis patients","volume":"10","author":"O Kwon","year":"2015","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"CHOIR investigators. Correction of anemia with Epoetin alfa in chronic kidney disease","volume":"355","author":"AK Singh","year":"2006","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"CREATE investigators: Normalization of haemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"TB Dr\u00fceke","year":"2006","journal-title":"N Engl J Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"TREAT Investigators. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"MA Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1681\/ASN.2010020173","article-title":"Naturally Occurring Higher Hemoglobin Concentration Does Not Increase Mortality among Hemodialysis Patients","volume":"22","author":"DA Goodkin","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.ajkd.2011.07.014","article-title":"Erythropoiesis-stimulating agent responsiveness and mortality in hemodialysis patients: results from a cohort study from the dialysis registry in Japan","volume":"59","author":"S Fukuma","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0272-6386(04)01086-8","article-title":"Epoetin requirements predict mortality in hemodialysis patients","volume":"44","author":"Y Zhang","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1093\/ndt\/gfq073","article-title":"Mortality in incident haemodialysis patients: time-dependent haemoglobin levels and erythropoiesis-stimulating agent dose are independent predictive factors in the ANSWER study","volume":"25","author":"J Fort","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1093\/ndt\/gfu272","article-title":"Age and anemia management: relationship of hemoglobin levels with mortality might differ between elderly and nonelderly hemodialysis patients","volume":"29","author":"N Hanafusa","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"c91","DOI":"10.1159\/000335979","article-title":"Disappearance of association in diabetic patients on hemodialysis between anemia and mortality risk: the Japan dialysis outcomes and practice pattern study","volume":"120","author":"M Inaba","year":"2012","journal-title":"Nephron Clinical Practice"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/ndt\/gfm929","article-title":"Influence of atherosclerosis on the relationship between anaemia and mortality risk in haemodialysis patients","volume":"23","author":"K Maekawa","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0002-9343(03)00366-8","article-title":"Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States","volume":"115","author":"R Agarwal","year":"2003","journal-title":"Am J Med"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/ajkd.2002.30542","article-title":"Hemodialysis-associated hypertension: pathophysiology and therapy","volume":"39","author":"MP H\u00f6rl","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.0894-0959.2004.17323.x","article-title":"Role of sodium and volume in the pathogenesis of hypertension in hemodialysis","volume":"17","author":"J Wilson","year":"2004","journal-title":"Semin Dial"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000046262","article-title":"Risk factors for hypertension in chronic hemodialysis patients: baseline data from the HEMO study","volume":"21","author":"MV Rocco","year":"2001","journal-title":"Am J Nephrol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1046\/j.1523-1755.2002.00636.x","article-title":"United States Renal Data System. Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4","volume":"62","author":"RN Foley","year":"2002","journal-title":"Study. Kidney Int"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/ajkd.1998.v32.pm9669435","article-title":"Noncompliance in hemodialysis: predictors and survival analysis","volume":"32","author":"JE Leggat Jr","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"ref56","first-page":"45","article-title":"Effect of recombinant human erythropoietin therapy on ambulatory blood pressure and heart rate in chronic haemodialysis patients","volume":"7","author":"P van de Borne","year":"1992","journal-title":"Nehrol Dial Transplant"},{"key":"ref57","first-page":"811","article-title":"Erythropoietin for anaemia in haemodialysis patients: results of a maintenance study; the Canadian Erythropoietin Study Group","volume":"7","author":"N1 Muirhead","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/ajkd.1998.v32.pm9740167","article-title":"Association between human recombinant EPO and peripheral vascular disease in diabetic patients receiving peritoneal dialysis","volume":"32","author":"M Wakeen","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"ref59","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/ki.2014.114","article-title":"Association between hemoglobin variability, serum ferritin levels, and adverse events\/mortality in maintenance hemodialysis patients","volume":"86","author":"T Kuragano","year":"2014","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"ref60","first-page":"ii5","article-title":"EBPG guideline on dialysis strategies","volume":"22","author":"J Tattersall","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1744-9987.2010.00836.x","article-title":"2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease","volume":"14","author":"Y Tsubakihara","year":"2010","journal-title":"Ther Apher Dial"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0169117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T02:36:08Z","timestamp":1658370968000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0169117"}},"subtitle":[],"editor":[{"given":"Hideharu","family":"Abe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,3]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0169117","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,3]]}}}